LENZ Therapeutics Stock Quote LENZ - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

16.41

Bid

15.50

Ask

18.11

Volume

188,715

15.61 Day's Range 16.62

15.05 52 Week Range 24.59

Market Cap

947.655M

Previous Close

15.81

Open

16.00

Last Trade

297

16.41

(priorref)

Last Trade Time

Financial Volume

$ 3,058,140

VWAP

16.2051

Average Volume (3m)

134,974

Shares Outstanding

57,996,000

Dividend Yield

PE Ratio

-7.60

Earnings Per Share (EPS)

-2.15

Revenue

Net Profit

-124.65M

Graphite Bio Inc is a clinical-stage gene-editing company harnessing gene integration to develop a new class of therapies to cure serious and life-threatening diseases. Its gene-editing platform allows to precisely correct mutations, replace entire disease-causing genes with normal genes, or insert ... Graphite Bio Inc is a clinical-stage gene-editing company harnessing gene integration to develop a new class of therapies to cure serious and life-threatening diseases. Its gene-editing platform allows to precisely correct mutations, replace entire disease-causing genes with normal genes, or insert new genes into predetermined, safe locations. Its lead product candidate GPH101 is a differentiated approach with the potential to directly correct the mutation that causes sickle cell disease (SCD) and restore normal adult hemoglobin (HgbA) expression. All of the company's long-lived assets are based in the United States. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.lenz-tx.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

LENZ Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker LENZ. The last closing price for LENZ Therapeutics was $15.81. Over the last year, LENZ Therapeutics shares have traded in a share price range of $ 15.05 to $ 24.59.

LENZ Therapeutics currently has 57,996,000 shares outstanding. The market capitalization of LENZ Therapeutics is $947.65 million. LENZ Therapeutics has a price to earnings ratio (PE ratio) of -7.60.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.91	5.87096774194	15.5	16.715	15.05	237912	15.9640957	CS
4	-5.28	-24.3430152144	21.69	22.07	15.05	118738	17.22512053	CS
12	0.43	2.69086357947	15.98	24.59	15.05	134974	18.35911492	CS
26	0.43	2.69086357947	15.98	24.59	15.05	134974	18.35911492	CS
52	0.43	2.69086357947	15.98	24.59	15.05	134974	18.35911492	CS
156	0.43	2.69086357947	15.98	24.59	15.05	134974	18.35911492	CS
260	0.43	2.69086357947	15.98	24.59	15.05	134974	18.35911492	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NUVOHoldco Nuvo Group DG Ltd	4.71 (2,040.91%)	106.68k
XBPXBP Europe Holdings Inc	$ 2.20 (67.94%)	18.82M
NUWENewellis Inc	$ 0.2101 (57.97%)	72.29M
VWEVintage Wine Estates Inc	$ 0.36 (55.17%)	790.52k
ENVXEnovix Corporation	$ 9.50 (45.93%)	25.83M
XPELXPEL Inc	$ 32.84 (-38.95%)	2.29M
PLTNPlutoniam Acquisition Corporation	$ 6.35 (-30.60%)	104.83k
ARAYAccuray Incorporated	$ 1.535 (-29.26%)	5.31M
BONBon Natural Life Ltd	$ 2.75 (-28.57%)	729.3k
HSDTHelius Medical Technologies Inc	$ 2.65 (-26.39%)	197.13k
JAGXJaguar Health Inc	$ 0.2932 (30.31%)	184.28M
SQQQProShares UltraPro Short QQQ	$ 11.78 (-3.60%)	141.24M
FFIEFaraday Future Intelligent Electric Inc	$ 0.0402 (-12.80%)	116.5M
AAPLApple Inc	$ 173.03 (2.20%)	95.38M
ALLRAllarity Therapeutics Inc	$ 1.1901 (-13.13%)	94.38M